-
Something wrong with this record ?
Do wolframin, P-glycoprotein, and GRP78/BiP cooperate to alter the response of L1210 cells to endoplasmic reticulum stress or drug sensitivity
S. Kurekova, L. Pavlikova, M. Seres, V. Bohacova, J. Spaldova, A. Breier, Z. Sulova
Status not-indexed Language English Country England, Great Britain
Document type Journal Article
Grant support
VEGA 2/0070/19, VEGA 2/0159/19 VEGA 2/0171/21, VEGA2/0046/24
Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences
APVV-19-0093
Slovak Agency for Research and Development
NLK
BioMedCentral
from 2001-12-01
BioMedCentral Open Access
from 2001
Directory of Open Access Journals
from 2001
Free Medical Journals
from 2001
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2001-11-01
Open Access Digital Library
from 2001-01-01
Open Access Digital Library
from 2001-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
Springer Nature OA/Free Journals
from 2001-12-01
- Publication type
- Journal Article MeSH
In previous research, we revealed that murine leukemia cells L1210 with induced expression of P-glycoprotein (P-gp, a membrane drug transporter, product of the Abcb1 gene) are better able to withstand endoplasmic reticulum (ER) stress (ERS) than their P-gp negative counterparts. This was associated with increased GRP78/BiP expression and modulation of the expression of several other proteins active in the cellular response to ERS (like CHOP, spliced XBP1, 50-kDa ATF6 protein fragment and others) in P-gp positive cells. Wolframin is an ER transmembrane protein, product of the WFS1 gene whose mutations are associated with Wolfram syndrome. However, this protein is frequently overexpressed in cells undergoing ERS and its expression may accompany changes in the above ERS markers. Therefore, our aim in this work was to investigate wolframin expression in P-gp-negative and P-gp-positive murine leukemia L1210 cells in relation to ERS related proteins in normal or ERS condition. We induced ERS in cells either by blocking N-glycosylation in the ER with tunicamycin or by blocking ER Ca2+-ATPase activity with thapsigargin, as known ER stressors. The results of this paper demonstrated increased wolframin expression in P-gp positive cells compared to P-gp negative cells. Immunoprecipitation experiments revealed the formation of complexes between wolframin and ERS related proteins (PERK, ATF6 and GRP78/BiP), the amount of which varied depending on the presence of the above ER stressors.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25008459
- 003
- CZ-PrNML
- 005
- 20250422095621.0
- 007
- ta
- 008
- 250408s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12935-025-03661-w $2 doi
- 035 __
- $a (PubMed)39920654
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kurekova, Simona $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia $u Institute of Biology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15, Olomouc, Czechia
- 245 10
- $a Do wolframin, P-glycoprotein, and GRP78/BiP cooperate to alter the response of L1210 cells to endoplasmic reticulum stress or drug sensitivity / $c S. Kurekova, L. Pavlikova, M. Seres, V. Bohacova, J. Spaldova, A. Breier, Z. Sulova
- 520 9_
- $a In previous research, we revealed that murine leukemia cells L1210 with induced expression of P-glycoprotein (P-gp, a membrane drug transporter, product of the Abcb1 gene) are better able to withstand endoplasmic reticulum (ER) stress (ERS) than their P-gp negative counterparts. This was associated with increased GRP78/BiP expression and modulation of the expression of several other proteins active in the cellular response to ERS (like CHOP, spliced XBP1, 50-kDa ATF6 protein fragment and others) in P-gp positive cells. Wolframin is an ER transmembrane protein, product of the WFS1 gene whose mutations are associated with Wolfram syndrome. However, this protein is frequently overexpressed in cells undergoing ERS and its expression may accompany changes in the above ERS markers. Therefore, our aim in this work was to investigate wolframin expression in P-gp-negative and P-gp-positive murine leukemia L1210 cells in relation to ERS related proteins in normal or ERS condition. We induced ERS in cells either by blocking N-glycosylation in the ER with tunicamycin or by blocking ER Ca2+-ATPase activity with thapsigargin, as known ER stressors. The results of this paper demonstrated increased wolframin expression in P-gp positive cells compared to P-gp negative cells. Immunoprecipitation experiments revealed the formation of complexes between wolframin and ERS related proteins (PERK, ATF6 and GRP78/BiP), the amount of which varied depending on the presence of the above ER stressors.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pavlikova, Lucia $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia
- 700 1_
- $a Seres, Mario $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia
- 700 1_
- $a Bohacova, Viera $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia
- 700 1_
- $a Spaldova, Jana $u Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 81237, Bratislava, Slovakia
- 700 1_
- $a Breier, Albert $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia. albert.breier@stuba.sk $u Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 81237, Bratislava, Slovakia. albert.breier@stuba.sk
- 700 1_
- $a Sulova, Zdena $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia. zdena.sulova@savba.sk
- 773 0_
- $w MED00008210 $t Cancer cell international $x 1475-2867 $g Roč. 25, č. 1 (2025), s. 35
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39920654 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250408 $b ABA008
- 991 __
- $a 20250422095622 $b ABA008
- 999 __
- $a ok $b bmc $g 2306381 $s 1245534
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 25 $c 1 $d 35 $e 20250207 $i 1475-2867 $m Cancer cell international $n Cancer Cell Int $x MED00008210
- GRA __
- $a VEGA 2/0070/19, VEGA 2/0159/19 VEGA 2/0171/21, VEGA2/0046/24 $p Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences
- GRA __
- $a APVV-19-0093 $p Slovak Agency for Research and Development
- LZP __
- $a Pubmed-20250408